Professional Documents
Culture Documents
Jordi Cadiz 2013
Jordi Cadiz 2013
Jordi Cadiz 2013
Usosylimitacionesdelaoxigenacinhiperbrica
(OHB/HBOT)enlaactualidad:
perspectivasdesdelaevaluacindetecnologas,yla
medicinabasadaenlaevidencia.
Jordi M.GolFreixa
jmgol@isciii.es
INSTITUTODESALUDCARLOSIII
AGENCIADEEVALUACINDETECNOLOGASSANITARIAS
(AETS)
OHBparaquienen2013?
Cualessonlasindicaciones
Robustezdelasmismas
Implicaciones
OHBparaquienen2013?
Cualessonlasindicaciones:
Lgicafisiopatolgica.
Experienciaclnica:seriesclnicas.
Quieneshanhecholaslistas:
Sociedadescientficas
Aseguradoras
Organismosreguladores
Otros
Comosehanhecholaslistas
Evolucinhistrica
[Robustezdelasmismas]
[Implicaciones]
IndicacionescubiertasporMEDICARE
20.29 HyperbaricOxygenTherapy
(Rev.48,Issued:031706;Effective/ImplementationDates:061906)CIM3510ForpurposesofcoverageunderMedicare,hyperbaric
oxygen(HBO)therapyisamodalityinwhichtheentirebodyisexposedtooxygenunderincreasedatmosphericpressure.
A.CoveredConditions:ProgramreimbursementforHBOtherapywillbelimited tothatwhichisadministeredinachamber(including
theonemanunit)andislimitedtothefollowingconditions:
l.Acutecarbonmonoxideintoxication,
2.Decompressionillness,
3.Gasembolism,
4.Gasgangrene,
5.Acutetraumaticperipheralischemia.HBOtherapyisavaluableadjunctivetreatmenttobeusedincombinationwithaccepted
standardtherapeuticmeasureswhenlossoffunction,limb,orlifeisthreatened.
6.Crushinjuriesandsuturingofseveredlimbs.Asinthepreviousconditions,HBOtherapywouldbeanadjunctivetreatmentwhenloss
offunction,limb,orlifeisthreatened.
7.Progressivenecrotizinginfecctions (necrotizingfasciitis),
8.Acuteperipheralarterialinsufficiency,
9.Preparationandpreservationofcompromisedskingrafts(notforprimarymanagementofwounds),
10.Chronicrefractoryosteomyelitis,unresponsivetoconventionalmedicalandsurgicalmanagement,11.Osteoradionecrosis asan
adjuncttoconventionaltreatment,
12.Softtissueradionecrosis asanadjuncttoconventionaltreatment,
13.Cyanidepoisoning,
14.Actinomycosis,onlyasanadjuncttoconventional therapywhenthediseaseprocessisrefractorytoantibioticsandsurgical
treatment,
15.Diabeticwoundsofthelowerextremitiesinpatientswhomeetthefollowingthreecriteria:
a.PatienthastypeIortypeIIdiabetesandhasalowerextremitywoundthatisduetodiabetes;
b.PatienthasawoundclassifiedasWagnergradeIIIorhigher;and
c.Patienthasfailedanadequatecourseofstandardwoundtherapy.
TheuseofHBOtherapyiscoveredasadjunctivetherapyonlyaftertherearenomeasurablesignsofhealingforatleast30days of
treatmentwithstandardwoundtherapyandmustbeusedinadditiontostandardappropriateoffloading,andnecessarytreatmentto
resolveanyinfectionthatmightbepresent.Failuretorespondtostandardwoundcareoccurswhentherearenomeasurablesigns of
healingforatleast30consecutivedays.Woundsmustbeevaluatedatleastevery30daysduringadministrationofHBO
therapy.Continued treatmentwithHBOtherapyisnotcoveredifmeasurablesignsofhealinghavenotbeendemonstratedwithinany
30dayperiodoftreatment.
NocubiertasporMEDICARE
20.29 HyperbaricOxygenTherapy
B.Noncovered Conditions
Allotherindicationsnotspecifiedunder270.4(A)arenotcoveredundertheMedicareprogram.Noprogrampaymentmaybemade
foranyconditionsotherthanthoselistedin
270.4(A).
NoprogrampaymentmaybemadeforHBOinthe treatmentofthefollowingconditions:
1.Cutaneous,decubitus,andstasisulcers
2.Chronicperipheralvascularinsufficiency
3.Anaerobicsepticemiaandinfectionotherthanclostridial
4.Skinburns(thermal).
5.Senility.
6.Myocardialinfarction.
7.Cardiogenic shock.
8.Sicklecellanemia.
9.Acutethermalandchemicalpulmonarydamage,i.e.,smokeinhalationwith
pulmonary
10.Acuteorchroniccerebralvascularinsufficiency.
11.Hepaticnecrosis.
12.Aerobicsepticemia.
13.Nonvascularcausesofchronicbrainsyndrome(Picksdisease,Alzheimersdisease,Korsakoffs disease)
14.Tetanus.
15.Systemicaerobicinfection.
16.Organtransplantation.
17.Organstorage.
18.Pulmonaryemphysema.
19.Exceptionalbloodlossanemia.
20.MultipleSclerosis.
21.ArthriticDiseases.
22.Acutecerebraledema.
The7thEuropeanConsensusConferenceonhyperbaricMedicine,Lille.
(ECC7)2004.
INDICACIN
NIVEL DE EVIDENCIA
B
B
B
B
B
C
C
C
B
C
C
C
C
C
C
C
C
C
C
C
C
C
The7thEuropeanConsensusConferenceon
HyperbaricMedicine,Lille. (ECC7).
Indicacionesaceptadas,segnnivelde
evidencia:
NivelA: Dobleciego,aleatorio,muestras
grandes
NivelB: Dobleciego,aleatoriodeunasola
muestraopequeosestudios
NivelC: Seriesclnicas,opininoconsensode
expertos
Aspectosmetodolgicosyde
robustez:
Validezdelasseriesclnicas.
Validezexterna:generalizabilidad,estimacinde
efectopoblacional.Seleccindecasos
Validezinterna:controldesesgos.Calidad
metodologica deldiseo
Validezdeconstructo,oconceptual.
Calidaddelaevidenciaversus fuerzadelas
recomendaciones
Qu hacerantelaevidenciainadecuada?
NICE
Aseguradoras
Proveedoreslibres
Profesionaleslibres
Sociedadescientificas yprofesionales